XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents $ 9,263,560 $ 5,345,967
Accounts receivable, net 1,547,801 1,896,163
Inventories, net 1,565,268 1,399,865
Prepaid expenses and other current assets 535,558 573,462
Total Current Assets 12,912,187 9,215,457
Operating lease assets with right of use, net 406,915 508,743
Equipment, net 190,736 194,283
Investment in Jiangxi Myomo Medical Assistive Appliance Co. Ltd. 115,287 132,489
Other assets 111,034 111,034
Total Assets 13,736,159 10,162,006
Current Liabilities:    
Accounts payable and accrued expenses 3,475,543 3,086,932
Current operating lease liability 275,028 353,701
Income taxes payable 182,768 140,650
Deferred revenue 747 20,653
Total Current Liabilities 3,934,086 3,601,936
Deferred revenue, net of current portion 312 498
Non-current operating lease liability 169,770 200,207
Total Liabilities 4,104,168 3,802,641
Commitments and Contingencies 0 0
Stockholders’ Equity:    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued or outstanding 0 0
Common stock par value $0.0001 per share, 65,000,000 shares authorized; 20,922,530 and 7,750,635 shares issued as of March 31, 2023 and December 31, 2022, respectively; and 20,922,503 and 7,750,608 shares outstanding at March 31, 2023 and December 31, 2022, respectively 2,092 775
Additional paid-in capital 100,954,887 95,105,071
Accumulated other comprehensive income 109,015 43,227
Accumulated deficit (91,427,539) (88,783,244)
Treasury stock, 27 shares at cost (6,464) (6,464)
Total Stockholders’ Equity 9,631,991 6,359,365
Total Liabilities and Stockholders’ Equity $ 13,736,159 $ 10,162,006